hERG Inhibition: Difference between revisions

From ACD Percepta
Jump to navigation Jump to search
Kristina (talk | contribs)
Created page with "==Overview== <br /> Cardiotoxicity of drug-like compounds associated with human ether-a-go-go (hERG) channel inhibition is becoming more and more common cause of drug candida..."
 
Kristina (talk | contribs)
Line 18: Line 18:
<br />
<br />


[[Image:herg_inhibition.png|center]]
[[Image:Herg_inhibition.png|center]]
<br />
<br />



Revision as of 13:32, 29 May 2012

Overview


Cardiotoxicity of drug-like compounds associated with human ether-a-go-go (hERG) channel inhibition is becoming more and more common cause of drug candidates’ attrition. The hERG potassium channel is required for normal cardiac depolarization and its blockage can lead to cardiac QT interval prolongation and life threatening arrhythmias.

Using hERG inhibition module, you have the capability to quickly identify hERG inhibitors. Training of models using usually very large ‘in-house’ experimental (screening) data of hERG inhibition would expand the Applicability Domain of the model and would produce reliable predictions for compounds synthesized in your company. Moreover, training allows customization of our model to ensure that it correctly handles the data originating from the particular screening protocol used in your company that may significantly differ from standard protocols described in the literature.

Features

  • The binomial QSAR model utilizes a training set of more than 600 compounds with experimental results mainly collected from the published hERG inhibition studies by patch-clamp method.
  • Predicts the probability for a compound to inhibit hERG channel at clinically relevant concentrations (Ki < 10 μM).
  • Calculates Reliability Index (RI values) of predictions that indicate whether tested compounds belong to Applicability Domain of predictive model.
  • Performs a similarity search and displays top 5 most similar structures from the training set of the model along with their names, experimental results, and literature references.
  • Training of the model using ‘in-house’ data generated by ‘in-house’ screening protocol.


Interface



  1. Estimated probability of a compound being human ether-a-go-go (hERG) channel inhibitor.
  2. Indication of the prediction reliability along with the Reliability Index value:
    • RI < 0.3 – Not Reliable,
    • RI in range 0.3-0.5 – Borderline Reliability,
    • RI in range 0.5-0.75 – Moderate Reliability,
    • RI >= 0.75 – High Reliability
  3. Up to 5 similar structures in the training set with names, experimental results (Inhibitor, Non-inhibitor, Inconclusive data), and references


Technical information